Since October 2025, DIXI medical began transitioning to a direct sales model in the United States. As of today, we operate exclusively through direct sales in the U.S. This milestone allows us to work directly with clinicians and healthcare institutions, delivering responsive support, competitive pricing, and seamless access to our technologies.

"The U.S. market is a key focus for DIXI medical, and we are thrilled to bring our team closer to the clinicians who trust our solutions. Operating exclusively through direct sales means we can provide unmatched service, strengthen partnerships, and accelerate innovation in epilepsy care. Our team is ready and excited to support clinicians nationwide," said Krisahn Gren, Vice President of Sales for the U.S.

Since joining DIXI medical, Krisahn has been shaping a high-performing team that is now nearly complete, with highly motivated and experienced professionals dedicated to transforming epilepsy care and delivering comprehensive clinical support across the country.

Education remains a cornerstone of our mission. Through our flagship SEEG training program, we continue to empower clinicians with hands-on learning and expert guidance. In February 2026, we will host the first-ever Pediatric SEEG course in South Carolina, a milestone event addressing the unique complexities of SEEG in children. Shortly after, at the end of March, our flagship SEEG course will return, offering an intensive, expert-led experience designed to advance clinical practice and strengthen skills for epilepsy surgery teams.

We look forward to continuing this next chapter, serving the U.S. market directly, and reinforcing our leadership in precision epilepsy care through innovation,education, and collaboration.

→ Contact our U.S. team at info@diximedus.com or at 1-888-664-DIXI (3494).

‍